Menu

Filtros : "2019" "Blood" Limpar

Filtros

Refine with date range

  • 1

1 - 3 (3 records)

  • Artigo de periodico

    Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study (2019)

    Lee, Jong Wook; Fontbrune, Flore Sicre de; Lee, Lily Wong Lee; Pessoa, Viviani; Gualandro, Sandra Fátima Menosi; Fuereder, Wolfgang; Ptushkin, Vadim; Rottinghaus, Scott T; Volles, Lori; Shafner, Lori

    Source: Blood. Unidade: FM

    Subjects: DOENÇAS HEMATOLÓGICAS, ANTICORPOS MONOCLONAIS, ADULTOS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LEE, Jong Wook et al. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood, v. 133, n. 6, p. 530-539, 2019Tradução . . Disponível em: https://doi.org/10.1182/blood-2018-09-876136. Acesso em: 03 nov. 2024.

    • APA

      Lee, J. W., Fontbrune, F. S. de, Lee, L. W. L., Pessoa, V., Gualandro, S. F. M., Fuereder, W., et al. (2019). Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood, 133( 6), 530-539. doi:10.1182/blood-2018-09-876136

    • NLM

      Lee JW, Fontbrune FS de, Lee LWL, Pessoa V, Gualandro SFM, Fuereder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study [Internet]. Blood. 2019 ; 133( 6): 530-539.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-876136

    • Vancouver

      Lee JW, Fontbrune FS de, Lee LWL, Pessoa V, Gualandro SFM, Fuereder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L. Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study [Internet]. Blood. 2019 ; 133( 6): 530-539.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-876136

  • Artigo de periodico

    Novel pathways of self- and cross-tolerance in monocytes (2019)

    Farsky, Sandra Helena Poliselli

    Source: Blood. Unidade: FCF

    Subjects: MONÓCITOS, SEPSE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FARSKY, Sandra Helena Poliselli. Novel pathways of self- and cross-tolerance in monocytes. Blood, v. 134, n. 2, p. 101-103, 2019Tradução . . Disponível em: https://doi.org/10.1182/blood.2019001532. Acesso em: 03 nov. 2024.

    • APA

      Farsky, S. H. P. (2019). Novel pathways of self- and cross-tolerance in monocytes. Blood, 134( 2), 101-103. doi:10.1182/blood.2019001532

    • NLM

      Farsky SHP. Novel pathways of self- and cross-tolerance in monocytes [Internet]. Blood. 2019 ; 134( 2): 101-103.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood.2019001532

    • Vancouver

      Farsky SHP. Novel pathways of self- and cross-tolerance in monocytes [Internet]. Blood. 2019 ; 134( 2): 101-103.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood.2019001532

  • Artigo de periodico-carta/editorial

    Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] (2019)

    Campos, Lívia Weijenborg; Zenatti, Priscila Pini ; Pissinato, Leonardo Granato ; Rodrigues, Gisele Olinto Libanio; Artico, Leonardo Luís ; Guimarães, Thais Rafael; Archangelo, Leticia Fröhlich ; Martínez, Leandro ; Brooks, Andrew J.; Yunes, Jose Andres

    Source: Blood. Unidade: FMRP

    Subjects: ONCOGENES, AMINOÁCIDOS, HIPERSENSIBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CAMPOS, Lívia Weijenborg et al. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2018-09-872945. Acesso em: 03 nov. 2024. , 2019

    • APA

      Campos, L. W., Zenatti, P. P., Pissinato, L. G., Rodrigues, G. O. L., Artico, L. L., Guimarães, T. R., et al. (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta]. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2018-09-872945

    • NLM

      Campos LW, Zenatti PP, Pissinato LG, Rodrigues GOL, Artico LL, Guimarães TR, Archangelo LF, Martínez L, Brooks AJ, Yunes JA. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] [Internet]. Blood. 2019 ; 133( 11): 1259-1263.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-872945

    • Vancouver

      Campos LW, Zenatti PP, Pissinato LG, Rodrigues GOL, Artico LL, Guimarães TR, Archangelo LF, Martínez L, Brooks AJ, Yunes JA. Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7RA cause receptor hypersensitivity. [Carta] [Internet]. Blood. 2019 ; 133( 11): 1259-1263.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1182/blood-2018-09-872945
  • 1

1 - 3 (3 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024